Lmedication SRL
The score of Lmedication shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +86 % Total assets +595 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lmedication's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 18 Jul 2025
- Year ended 31 Dec 2023filed on 09 Jul 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
Lmedication's financial analysis
- Solvency19.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lmedication
Lmedication's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0789.738.465
- VAT number
- BE0789738465
- Peppol
- Registered · 0208:0789738465 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Aug 2022
- Registered office
- 6221 Fleurus
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lmedication (SRL) has been based in Fleurus since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 39,690 € and equity of 44,934 €; its revenue is not published. Its solvency stands at 19.7%, below the median of its sector (41.5%).
Companies similar to Lmedication
Companies in the same business, of comparable size and area, outside its group.
- Parry Retail sale of pharmaceutical products Schaerbeek · balance sheet 228,483 €
- Apotheek DE Gaper Retail sale of pharmaceutical products Mortsel · balance sheet 228,107 €
- Pharmacie Defrance Retail sale of pharmaceutical products Jette · balance sheet 229,204 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Farmacare Retail sale of pharmaceutical products Aalst · balance sheet 226,083 €
- Jufarma Retail sale of pharmaceutical products Charleroi · balance sheet 223,918 €
- Lorophar Retail sale of pharmaceutical products Lincent · balance sheet 234,299 €
- Apoteek DE Decker Retail sale of pharmaceutical products Lebbeke · balance sheet 234,587 €
Frequently asked questions about Lmedication
What is the revenue of Lmedication?
Lmedication files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lmedication?
In Belgium, the VAT number is the company number prefixed with BE: BE0789738465 for Lmedication, if the company is VAT-registered. Its company number (CBE) is 0789.738.465.
Where is the registered office of Lmedication?
According to the CBE register, the registered office of Lmedication is in 6221 Fleurus.
What is the equity of Lmedication?
At the close of the 2025 financial year, the equity of Lmedication amounts to 44,934 €, a solvency of 19.7% of total assets.
Who manages Lmedication?
The register lists 1 active mandates at Lmedication. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lmedication
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →